The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 20, 2021

Filed:

Nov. 18, 2016
Applicants:

Public University Corporation Nagoya City University, Nagoya, JP;

The University of Tokyo, Tokyo, JP;

Inventors:

Yutaka Kondo, Nagoya, JP;

Keisuke Katsushima, Nagoya, JP;

Kazunori Kataoka, Tokyo, JP;

Kanjiro Miyata, Tokyo, JP;

Hyun Jin Kim, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 31/713 (2006.01); A61K 35/76 (2015.01); A61K 31/7088 (2006.01); C12N 15/00 (2006.01); A61K 9/00 (2006.01); A61K 47/60 (2017.01); A61P 35/00 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/0019 (2013.01); A61K 9/1075 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 35/76 (2013.01); A61K 47/60 (2017.08); A61P 35/00 (2018.01); C12N 15/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/111 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3513 (2013.01); C12N 2320/32 (2013.01);
Abstract

This invention provides an antitumor drug delivery formulation for treating a subject having a tumor more highly expressing a TUG1 gene than normal tissues or preventing the subject from tumor metastasis, comprising a polymeric micelle comprising a nucleic acid that suppresses high expression of the TUG1 gene as an active ingredient, wherein the polymeric micelle comprises a block copolymer having a cationic poly(amino acid) segment and a hydrophilic polymer chain segment and the nucleic acid, and wherein the nucleic acid is bound to a cationic group of the cationic poly(amino acid) segment to form a complex and/or the nucleic acid is incorporated in the micelle or attached into the micelle; and the polymeric micelle accumulates in the tumor.


Find Patent Forward Citations

Loading…